Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination cancer therapy with an AKT inhibitor and other anticancer agents

Combination cancer therapy with an AKT inhibitor and other anticancer agents

US Patent 8481503 · Granted Jul 9, 2013

Estimated economic value: $144,918,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Antitumor agent and method for tumor therapy2024
Method for reducing content of saturated hydrocarbon, and refined palm-based oil2023
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2021
Antitumor drug for intermittent administration of FGFR inhibitor2021
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in v2019
N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated 2019